MGMT and glioblastoma: Soon thereafter, in a retrospective analysis of data from the Stupp trial, Hegi et al. showed that benefit from TMZ chemotherapy was largely limited to patients with glioblastoma possessing a methylated O-6-methylguanine-DNA methyltransferase (MGMT) promoter (3).